These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12736970)

  • 1. Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance.
    Balogun MA; Laurichesse H; Ramsay ME; Sellwood J; Westmoreland D; Paver WK; Pugh SF; Zuckerman M; Pillay D; Wreghitt T
    Commun Dis Public Health; 2003 Apr; 6(1):34-9. PubMed ID: 12736970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance.
    Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ramsay ME;
    J Viral Hepat; 2008 Oct; 15(10):729-39. PubMed ID: 18637078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.
    Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ahmad F; Boxall E; Hale A; Hollyoak V; Ibrahim IB; Irving W; Meigh R; Mutton KJ; Patel BC; Paver WK; Pugh S; Taylor C; Turner AJ; Ramsay ME
    Epidemiol Infect; 2007 Apr; 135(3):417-26. PubMed ID: 16836798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996.
    Ramsay ME; Balogun MA; Collins M; Balraj V
    Commun Dis Public Health; 1998 Jun; 1(2):89-94. PubMed ID: 9644120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.
    May S; Ngui SL; Collins S; Lattimore S; Ramsay M; Tedder RS; Ijaz S
    J Clin Virol; 2015 Mar; 64():6-11. PubMed ID: 25728071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007.
    Brant LJ; Ramsay ME; Tweed E; Hale A; Hurrelle M; Klapper P; Ngui SL;
    J Clin Virol; 2010 Jun; 48(2):115-9. PubMed ID: 20399704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of hepatitis C in England and Wales.
    Balogun MA; Ramsay ME; Hesketh LM; Andrews N; Osborne KP; Gay NJ; Morgan-Capner P
    J Infect; 2002 Nov; 45(4):219-26. PubMed ID: 12423608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
    Dubois F; Desenclos JC; Mariotte N; Goudeau A
    Hepatology; 1997 Jun; 25(6):1490-6. PubMed ID: 9185773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.
    Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J
    J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
    Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
    Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
    Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
    J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Ansari MA; Irshad M; Agarwal SK; Chosdol K
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.
    Cavlek TV; Margan IG; Lepej SZ; Kolaric B; Vince A
    J Med Virol; 2009 Aug; 81(8):1348-53. PubMed ID: 19551819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of occult HCV infection among Hiv infected patients in Georgia.
    Gatserelia L; Sharvadze L; Karchava M; Dolmazashvili E; Tsertsvadze T
    Georgian Med News; 2014 Jan; (226):37-41. PubMed ID: 24523330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.